CVS

CVS

USD

CVS Health Corporation Common Stock

$78.080-0.360 (-0.459%)

Precio en Tiempo Real

Healthcare
Healthcare Plans
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$78.440

Máximo

$79.350

Mínimo

$77.560

Volumen

4.28M

Fundamentos de la Empresa

Capitalización de Mercado

99.1B

Industria

Healthcare Plans

País

United States

Estadísticas de Negociación

Volumen Promedio

7.31M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $43.56Actual $78.080Máximo $85.15

Noticias Relacionadas

PR Newswire

CVS Health to hold Investor Day on December 9, 2025

CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide...

Ver más
CVS Health to hold Investor Day on December 9, 2025
Analyst Upgrades

TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100

TD Cowen analyst Charles Rhyee maintains CVS Health with a Buy and raises the price target from $99 to $100.

Ver más
TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100
Reuters

Obamacare premiums double, adding post Halloween fright for US health insurance shoppers

Americans shopping for 2026 Obamacare health insurance plans are facing a more than doubling of monthly premiums on average and are likely to postpone signing up in hopes of a last-minute reprieve, or walk away, health experts say.

Ver más
Obamacare premiums double, adding post Halloween fright for US health insurance shoppers
PR Newswire

CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity

CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is...

Ver más
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Analyst Upgrades

Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health with a Outperform and raises the price target from $85 to $95.

Ver más
Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95
Analyst Upgrades

RBC Capital Maintains Outperform on CVS Health, Raises Price Target to $93

RBC Capital analyst Ben Hendrix maintains CVS Health with a Outperform and raises the price target from $81 to $93.

Analyst Upgrades

Cantor Fitzgerald Maintains Overweight on CVS Health, Raises Price Target to $95

Cantor Fitzgerald analyst Sarah James maintains CVS Health with a Overweight and raises the price target from $78 to $95.

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.